Cytovation ASAFinancingCytovation ASA bags additional US$6m to dr...Cytovation ASA has baged US$6m to advance Phase II development of its bi-specific pore-forming peptide candidate CY-101 in patients with adrenocortical carcinoma. more ➔
TraderfoxM&AKKR makes US$1.22bn tender for Swedish Bio...RWK Bidco AB, newly founded by the private equity firm KKR (Kohlberg Kravis Roberts & Co.), has identified Swedish separation specialist Biotage AB as a takeover target and submitted an official takeover … more ➔
adobe stock - JHVEPhoto PartnershipBoehringer Ingelheim inks deal with Tessal...Boehringer Ingelheim and synthetic lethality specialist Tessellate Bio have entered into an €500m biobucks global license agreement on oral first-in-class cancer treatments. more ➔
adobe stock - peterschreiber.media US tariff policy Roche and Novartis react to US tariffsDespite the World Trade Organisation’s (WTO) ban of tariffs on pharmaceuticals, US President Donald Trump has announced he would consider imposing tariffs on pharmaceutical products. In a fast reaction, … more ➔
Image by freepikDairy alternativesWhey Waste Finds New Life as ProteinFrench dairy heavyweight Bel Group has teamed up with Standing Ovation in a bid to transform surplus whey from cheese production into high-value casein proteins using precision fermentation. The collaboration … more ➔
uniqure NVGene TherapyAMT-130 gets FDA breakthrough therapy desi...Amsterdam-based uniQure NV’s gene therapy candidate AMT-130 has been granted FDA Breakthrough Therapy Designation for the treatment of the neurodegenerative Huntington’s disease. more ➔
RijksoverheidGovernanceNetherlands Sets Sights on Global Biotech...The Netherlands has set itself an ambitious goal: to be among the global leaders in biotechnology by 2040. This vision is backed by an initial commitment of €1.3 billion in funding. more ➔
123rf.com/guniitaNeurodegenerative DisordersNLS and Kadimastem: Swiss-israeli merger i...NLS Pharmaceutics secures US$2m equity funding and signs US$25m equity facility to support merger with Kadimastem (Israel) to combine expertise in aiming to become a leader in regenerative medicine in … more ➔
wikicommonsUnited KingdomUK Government invests millions into new he...UK focuses on digital health research: 600 british pounds (US$764m) for new data platform according to the five recommendations of the Sudlow report. more ➔
TIRmed Pharma ABImmunmodulationSwedish TIRmed Pharma raises 4,3m€ again...TIRmed Pharma secures 4,3m€ to advance immunomodulatory treatment options for atopic dermatitis into clinical development. Stockholm-based TIRmed Pharma has closed this funding round, led by Sciety … more ➔
Cytovation ASA
Traderfox
adobe stock - JHVEPhoto 
adobe stock - peterschreiber.media 
uniqure NV
Rijksoverheid
123rf.com/guniita
wikicommons
TIRmed Pharma AB